Humacyte's total assets for Q2 2025 were $138.79M, a decrease of -14.62% from the previous quarter. HUMA total liabilities were $134.74M for the fiscal quarter, a 6.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.